Does the DTC have a policy which defines timely decision-making and communication of outcomes? Where, due to unusual or unexpected circumstances, defined timeframes are unlikely to be achieved, is this explained to the relevant stakeholders and a realistic timeframe proposed? Is there a set agenda prior to each meeting? Is there provision for proactive and responsive agenda items and a mechanism for stakeholders to submit items for consideration? DTCs should be Does the DTC develop and follow an annual GP 10: both proactive and work plan informed by local issues and responsive to issues horizon scanning, nationally and arising and develop an internationally? annual work plan. GP 11: DTCs should Does the DTC undertake risk assessments undertake risk within the health service organisation with assessments within the respect to medicines use? When are health service identified, are strategies identified and organisation with recommended to mitigate that risk? respect to medicines use and apply strategies to mitigate that risk. GP 12: DTCs should Is there a framework for the identify and prioritise a implementation and ongoing monitoring of systems improvement decisions to ensure that criteria for plan and assign decision-making are being consistently responsibilities and applied? timeframes for Does the DTC identify and implement completion. quality improvement activities when needed, assigning responsibilities and timeframes for completion? GP 13: DTCs should Are the of reference and membership have in place monitoring regularly reviewed to reflect organisational systems to evaluate or functional changes? their effectiveness. Does the DTC use a meaningful tool to evaluate their current practice and progress? Is there an assurance process to monitor its effectiveness and to enable learning to be incorporated into future process improvements?
Does the DTC have a policy which defines timely decision-making and communication of outcomes? Where, due to unusual or unexpected circumstances, defined timeframes are unlikely to be achieved, is this explained to the relevant stakeholders and a realistic timeframe proposed? Is there a set agenda prior to each meeting? Is there provision for proactive and responsive agenda items and a mechanism for stakeholders to submit items for consideration? GP 10: DTCs should be both proactive and responsive to issues arising and develop an annual work plan. Does the DTC develop and follow an annual work plan informed by local issues and horizon scanning, nationally and internationally? GP 11: DTCs should undertake risk assessments within the health service organisation with respect to medicines use and apply strategies to mitigate that risk. Does the DTC undertake risk assessments within the health service organisation with respect to medicines use? When are identified, are strategies identified and recommended to mitigate that risk? GP 12: DTCs should identify and prioritise a systems improvement plan and assign responsibilities and timeframes for completion. Is there a framework for the implementation and ongoing monitoring of decisions to ensure that criteria for decision-making are being consistently applied? Does the DTC identify and implement quality improvement activities when needed, assigning responsibilities and timeframes for completion? GP 13: DTCs should have in place monitoring systems to evaluate their effectiveness. Are the of reference and membership regularly reviewed to reflect organisational or functional changes? Does the DTC use a meaningful tool to evaluate their current practice and progress? Is there an assurance process to monitor its effectiveness and to enable learning to be incorporated into future process improvements?
Appendix-6-DTC-checklist-version-1.docx